GLP-1 Receptor Expression Within the Human Heart

Glucagonlike peptide-1 receptor (GLP-1R) agonists, which are used to treat type 2 diabetes and obesity, reduce the rates of myocardial infarction and cardiovascular death. GLP-1R has been localized to the human sinoatrial node; however, its expression in ventricular tissue remains uncertain. Here we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinology
Main Authors: Baggio, Laurie L, Yusta, Bernardo, Mulvihill, Erin E, Cao, Xiemin, Streutker, Catherine J, Butany, Jagdish, Cappola, Thomas P, Margulies, Kenneth B, Drucker, Daniel J
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5939638/
https://ncbi.nlm.nih.gov/pubmed/29444223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2018-00004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados